Jetsumon Sattbongkot (Prachumsri)
@jspmalaria
Malaria researcher
ID: 132802702
http://www.Mahidolvivax.com 14-04-2010 06:30:05
213 Tweet
104 Followers
39 Following
We are so excited to have Jetsumon Sattbongkot (Prachumsri), head of Mahidol University Vivax Research Unit, as one of our keynote plenary speakers. She leads a team of researchers with experience in a range of skills, including #malaria #epidemiology, #diagnosis by microscopy, & in-vitro culture. 🦟
Did you miss the first #ICPVR2022 keynote by Prof Jetsumon Prachumsri Jetsumon Sattbongkot (Prachumsri)? The video will be posted on the conference website soon. While you're waiting, look at this pictorial summary by Drawnalism 🙌🏾
New findings from the Phase 2b trial of Jenner Institute's R21 #malaria #vaccine , reported in The Lancet Infectious Diseases, show a vaccine efficacy of 80% over 12 months of follow-up. This could eradicate the disease by 2040! Find out more 👉 ndm.ox.ac.uk/about/news/mal…
Congrats to our investigators on receiving the #NHMRC's Synergy grant to develop multiple strategies to interrupt #malaria transmission Burnet Institute Deakin University WEHI (Walter and Eliza Hall Institute) Melbourne School of Population and Global Health James B Freya Fowkes Leanne Robinson Julie Simpson @DoctorBaz #womeninstem
Michael Chew Wellcome And if does not work as hoped, community involvement,trial capacity & ownership Africa & Asia,trial design, data, investment allied social science, Dx,transmission,epidemiology, immunology,pathogen biology, economics can catalyse funding & hope in this awful & neglected infection
Very excited to be part of team SAMBAI. This represents the largest single NCI/CRUK award for cancer inequities ever. For Yemaachi Biotech to be one of 2 African partners (and the only biotech) responsible for centering large part of this work in Africa is both humbling and exciting.